RS59759B1 - Postupak za pripremanje jedinjenja n-(3,5-dimetilfenil)-n'-(2-trifluorometilfenil) gvanidina - Google Patents

Postupak za pripremanje jedinjenja n-(3,5-dimetilfenil)-n'-(2-trifluorometilfenil) gvanidina

Info

Publication number
RS59759B1
RS59759B1 RS20191669A RSP20191669A RS59759B1 RS 59759 B1 RS59759 B1 RS 59759B1 RS 20191669 A RS20191669 A RS 20191669A RS P20191669 A RSP20191669 A RS P20191669A RS 59759 B1 RS59759 B1 RS 59759B1
Authority
RS
Serbia
Prior art keywords
compound
formula
solid form
crystalline solid
dimethylphenyl
Prior art date
Application number
RS20191669A
Other languages
English (en)
Serbian (sr)
Inventor
José Amato
Original Assignee
Chemo Research S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Research S L filed Critical Chemo Research S L
Publication of RS59759B1 publication Critical patent/RS59759B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/02Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of guanidine from cyanamide, calcium cyanamide or dicyandiamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/06Purification or separation of guanidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20191669A 2015-08-11 2016-08-10 Postupak za pripremanje jedinjenja n-(3,5-dimetilfenil)-n'-(2-trifluorometilfenil) gvanidina RS59759B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ARP150102582A AR101498A1 (es) 2015-08-11 2015-08-11 Procedimiento para la preparación del compuesto n-(3,5-dimetilfenil)-n-(2-trifluorometilfenil)guanidina y su forma cristalina a
EP15382424 2015-08-11
EP16756641.3A EP3334707B1 (en) 2015-08-11 2016-08-10 A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine
PCT/EP2016/069033 WO2017025560A1 (en) 2015-08-11 2016-08-10 A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine

Publications (1)

Publication Number Publication Date
RS59759B1 true RS59759B1 (sr) 2020-02-28

Family

ID=56799434

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20191669A RS59759B1 (sr) 2015-08-11 2016-08-10 Postupak za pripremanje jedinjenja n-(3,5-dimetilfenil)-n'-(2-trifluorometilfenil) gvanidina

Country Status (21)

Country Link
US (1) US10343984B2 (enExample)
EP (1) EP3334707B1 (enExample)
JP (1) JP6748188B2 (enExample)
CN (1) CN107922322B (enExample)
AR (1) AR101498A1 (enExample)
BR (1) BR112018002614B1 (enExample)
CA (1) CA2994781A1 (enExample)
CY (1) CY1122481T1 (enExample)
DK (1) DK3334707T3 (enExample)
ES (1) ES2756580T3 (enExample)
HR (1) HRP20192301T1 (enExample)
HU (1) HUE046959T2 (enExample)
LT (1) LT3334707T (enExample)
MX (1) MX383481B (enExample)
PL (1) PL3334707T3 (enExample)
PT (1) PT3334707T (enExample)
RS (1) RS59759B1 (enExample)
RU (1) RU2737430C2 (enExample)
SI (1) SI3334707T1 (enExample)
SM (1) SMT201900747T1 (enExample)
WO (1) WO2017025560A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172842B (enExample) * 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
AU2962297A (en) * 1996-05-24 1998-01-05 Neurosearch A/S Phenyl derivatives useful as blockers of chloride channels
US8283370B2 (en) * 2008-10-03 2012-10-09 The United States Of America As Represented By The Secretary Of The Army Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
EP2766342B1 (en) * 2011-10-11 2016-02-10 Universidad Nacional de Quilmes Phenyl-guanidine derivatives

Also Published As

Publication number Publication date
ES2756580T3 (es) 2020-04-27
HK1256253A1 (en) 2019-09-20
DK3334707T3 (da) 2020-01-06
HUE046959T2 (hu) 2020-04-28
MX2018001548A (es) 2018-06-22
JP6748188B2 (ja) 2020-08-26
RU2737430C2 (ru) 2020-11-30
HRP20192301T1 (hr) 2020-03-20
SMT201900747T1 (it) 2020-03-13
JP2018525393A (ja) 2018-09-06
US10343984B2 (en) 2019-07-09
LT3334707T (lt) 2020-01-27
RU2018107840A3 (enExample) 2019-12-18
CY1122481T1 (el) 2021-01-27
BR112018002614A2 (enExample) 2018-10-02
MX383481B (es) 2025-03-14
CN107922322A (zh) 2018-04-17
EP3334707B1 (en) 2019-10-09
BR112018002614B1 (pt) 2023-04-11
EP3334707A1 (en) 2018-06-20
SI3334707T1 (sl) 2020-03-31
US20180244608A1 (en) 2018-08-30
WO2017025560A1 (en) 2017-02-16
PL3334707T3 (pl) 2020-05-18
PT3334707T (pt) 2020-01-14
RU2018107840A (ru) 2019-09-12
CN107922322B (zh) 2023-11-03
CA2994781A1 (en) 2017-02-16
AR101498A1 (es) 2016-12-21

Similar Documents

Publication Publication Date Title
CN115322158B (zh) 作为krasg12c蛋白抑制剂的取代喹唑啉类化合物
CN100402523C (zh) 杂环化合物及以其为有效成分的抗肿瘤药
EP3551617B1 (en) Compositions and methods related to pyridinoylpiperidine 5-ht1f agonists
TWI772424B (zh) 一種苯并呋喃類衍生物游離鹼的晶型及製備方法
KR102142797B1 (ko) 피리디닐아미노피리미딘 유도체의 메실레이트 염의 결정질 형태, 그의 제조 방법, 및 그의 용도
JP2015533778A (ja) がんの治療のための新規フェニル−ピリジン/ピラジンアミド
CN112920176B (zh) 可诱导prc2蛋白复合物核心亚基降解的双功能化合物和药物组合物及应用
CN110066276B (zh) 芳香杂环化合物、其中间体、制备方法、药物组合物和应用
CN109400598B (zh) 盐酸小檗碱与乳酸共晶、其制备方法和应用
WO2022242725A1 (zh) 一类新型蛋白降解剂及其应用
JP7496440B2 (ja) Trka阻害剤
RS59759B1 (sr) Postupak za pripremanje jedinjenja n-(3,5-dimetilfenil)-n'-(2-trifluorometilfenil) gvanidina
HK1256253B (en) A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine
ES2881960T3 (es) Inhibidores de proteina quinasa
TWI853707B (zh) 萘并呋喃取代的戊二醯亞胺類化合物的晶型、製備方法及其應用
WO2015096119A1 (zh) 氯卡色林盐及其晶体、其制备方法和用途
KR102218861B1 (ko) 단백질 키나아제 저해제인 신규한 페녹시 아로마틱 아마이드 유도체
AU2023418787A1 (en) Naphthylamide compound, and preparation method therefor and use thereof
HK40007699B (en) Compositions and methods related to pyridinoylpiperidine 5-ht1f agonists
HK40007699A (en) Compositions and methods related to pyridinoylpiperidine 5-ht1f agonists